An ideal preparation for dermal regeneration

Skin renewal growth factors, the growth factor composites from porcine platelets

Kuo Hsien Wang, Yo Ping Greg Wu, Wen Cheng Lo

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The use of growth factor composites from platelets has been introduced to many areas of clinical applications and studies. With the richest source of growth factors (GFs), beneficial effects have been shown on tissue regeneration and wound healing. However, animal and clinical studies have revealed inconsistent outcomes with the use of platelet-derived growth factors (PDGFs), which were likely due to variations in the presence and concentrations of GFs between various sources. Autologous PDGFs are considered to be safer, but they are limited by the feasibility of large-scale production to be used extensively in the acute phase, greater surface area, or general cosmetic applications. This study employed a simple process to obtain growth factor composites from activated platelets of porcine origin, namely skin renewal growth factors (SRGF). The functions of SRGF were subsequently evaluated on cultured human fibroblasts, keratinocytes, and melanocytes. Our data revealed that SRGF significantly promoted the proliferation of fibroblasts, accompanied by increased expression of collagens (types I, III, IV, and VIII) and proteoglycans. Diminished proliferation and arrested differentiation of keratinocytes were evidenced by the attenuated expression of laminin V and keratin 10. In addition, SRGF also suppressed the growth of melanocytes and reduced the expression of microphthalmia-associated transcription factor (MITF), tyrosinase, and paired box 3 (PAX3), which mediates melanogensis. Our results suggest that SRGF possesses beneficial properties and is a promising and cost-effective composition for the development of a safe cosmetic agent or topical products for skin regeneration. The development of SRGF may also provide an alternative strategy for tissue engineering.

Original languageEnglish
Pages (from-to)613-623
Number of pages11
JournalRejuvenation Research
Volume15
Issue number6
DOIs
Publication statusPublished - Dec 1 2012

Fingerprint

Regeneration
Intercellular Signaling Peptides and Proteins
Swine
Blood Platelets
Skin
Melanocytes
Platelet-Derived Growth Factor
Keratinocytes
Cosmetics
Keratin-10
Fibroblasts
Microphthalmia-Associated Transcription Factor
Collagen Type III
Monophenol Monooxygenase
Proteoglycans
Tissue Engineering
Collagen Type I
Wound Healing
Costs and Cost Analysis
Growth

ASJC Scopus subject areas

  • Ageing
  • Geriatrics and Gerontology

Cite this

An ideal preparation for dermal regeneration : Skin renewal growth factors, the growth factor composites from porcine platelets. / Wang, Kuo Hsien; Wu, Yo Ping Greg; Lo, Wen Cheng.

In: Rejuvenation Research, Vol. 15, No. 6, 01.12.2012, p. 613-623.

Research output: Contribution to journalArticle

@article{66a197ea642642118b6ef575d15af000,
title = "An ideal preparation for dermal regeneration: Skin renewal growth factors, the growth factor composites from porcine platelets",
abstract = "The use of growth factor composites from platelets has been introduced to many areas of clinical applications and studies. With the richest source of growth factors (GFs), beneficial effects have been shown on tissue regeneration and wound healing. However, animal and clinical studies have revealed inconsistent outcomes with the use of platelet-derived growth factors (PDGFs), which were likely due to variations in the presence and concentrations of GFs between various sources. Autologous PDGFs are considered to be safer, but they are limited by the feasibility of large-scale production to be used extensively in the acute phase, greater surface area, or general cosmetic applications. This study employed a simple process to obtain growth factor composites from activated platelets of porcine origin, namely skin renewal growth factors (SRGF). The functions of SRGF were subsequently evaluated on cultured human fibroblasts, keratinocytes, and melanocytes. Our data revealed that SRGF significantly promoted the proliferation of fibroblasts, accompanied by increased expression of collagens (types I, III, IV, and VIII) and proteoglycans. Diminished proliferation and arrested differentiation of keratinocytes were evidenced by the attenuated expression of laminin V and keratin 10. In addition, SRGF also suppressed the growth of melanocytes and reduced the expression of microphthalmia-associated transcription factor (MITF), tyrosinase, and paired box 3 (PAX3), which mediates melanogensis. Our results suggest that SRGF possesses beneficial properties and is a promising and cost-effective composition for the development of a safe cosmetic agent or topical products for skin regeneration. The development of SRGF may also provide an alternative strategy for tissue engineering.",
author = "Wang, {Kuo Hsien} and Wu, {Yo Ping Greg} and Lo, {Wen Cheng}",
year = "2012",
month = "12",
day = "1",
doi = "10.1089/rej.2012.1345",
language = "English",
volume = "15",
pages = "613--623",
journal = "Rejuvenation Research",
issn = "1549-1684",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - An ideal preparation for dermal regeneration

T2 - Skin renewal growth factors, the growth factor composites from porcine platelets

AU - Wang, Kuo Hsien

AU - Wu, Yo Ping Greg

AU - Lo, Wen Cheng

PY - 2012/12/1

Y1 - 2012/12/1

N2 - The use of growth factor composites from platelets has been introduced to many areas of clinical applications and studies. With the richest source of growth factors (GFs), beneficial effects have been shown on tissue regeneration and wound healing. However, animal and clinical studies have revealed inconsistent outcomes with the use of platelet-derived growth factors (PDGFs), which were likely due to variations in the presence and concentrations of GFs between various sources. Autologous PDGFs are considered to be safer, but they are limited by the feasibility of large-scale production to be used extensively in the acute phase, greater surface area, or general cosmetic applications. This study employed a simple process to obtain growth factor composites from activated platelets of porcine origin, namely skin renewal growth factors (SRGF). The functions of SRGF were subsequently evaluated on cultured human fibroblasts, keratinocytes, and melanocytes. Our data revealed that SRGF significantly promoted the proliferation of fibroblasts, accompanied by increased expression of collagens (types I, III, IV, and VIII) and proteoglycans. Diminished proliferation and arrested differentiation of keratinocytes were evidenced by the attenuated expression of laminin V and keratin 10. In addition, SRGF also suppressed the growth of melanocytes and reduced the expression of microphthalmia-associated transcription factor (MITF), tyrosinase, and paired box 3 (PAX3), which mediates melanogensis. Our results suggest that SRGF possesses beneficial properties and is a promising and cost-effective composition for the development of a safe cosmetic agent or topical products for skin regeneration. The development of SRGF may also provide an alternative strategy for tissue engineering.

AB - The use of growth factor composites from platelets has been introduced to many areas of clinical applications and studies. With the richest source of growth factors (GFs), beneficial effects have been shown on tissue regeneration and wound healing. However, animal and clinical studies have revealed inconsistent outcomes with the use of platelet-derived growth factors (PDGFs), which were likely due to variations in the presence and concentrations of GFs between various sources. Autologous PDGFs are considered to be safer, but they are limited by the feasibility of large-scale production to be used extensively in the acute phase, greater surface area, or general cosmetic applications. This study employed a simple process to obtain growth factor composites from activated platelets of porcine origin, namely skin renewal growth factors (SRGF). The functions of SRGF were subsequently evaluated on cultured human fibroblasts, keratinocytes, and melanocytes. Our data revealed that SRGF significantly promoted the proliferation of fibroblasts, accompanied by increased expression of collagens (types I, III, IV, and VIII) and proteoglycans. Diminished proliferation and arrested differentiation of keratinocytes were evidenced by the attenuated expression of laminin V and keratin 10. In addition, SRGF also suppressed the growth of melanocytes and reduced the expression of microphthalmia-associated transcription factor (MITF), tyrosinase, and paired box 3 (PAX3), which mediates melanogensis. Our results suggest that SRGF possesses beneficial properties and is a promising and cost-effective composition for the development of a safe cosmetic agent or topical products for skin regeneration. The development of SRGF may also provide an alternative strategy for tissue engineering.

UR - http://www.scopus.com/inward/record.url?scp=84872694645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872694645&partnerID=8YFLogxK

U2 - 10.1089/rej.2012.1345

DO - 10.1089/rej.2012.1345

M3 - Article

VL - 15

SP - 613

EP - 623

JO - Rejuvenation Research

JF - Rejuvenation Research

SN - 1549-1684

IS - 6

ER -